Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- Little cash and receivables against the short-term debts.
Gross margin
€ 103,870
▼ 8% vs 2024
Profit
Growing€ 75,588
▲ 22% vs 2024
Debts
High€ 4 million
▼ 6% vs 2024
SANIFORT PHARMA from Leuven, company number BE0882765326, closed financial year 2025 with a result of € 75,588 after tax. For that financial year SANIFORT PHARMA recorded a gross margin of € 103,870 and equity of € -3.6 million. Compared with financial year 2024, the result moved from € 61,896 to € 75,588. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 28, 2026.
What happened at SANIFORT PHARMA?
What happened at SANIFORT PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 75,588 (▲ 22% vs 2024). Source: NBB ↗
- Leo Derieuw became a director. NBB
- Johan Jacobs became a director. NBB
- Karel Vandecasteele became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 475,548 loss in 2022 to € 75,588 profit in 2025.
Paid € 1,244 in corporate taxes since 2022.
Best year ever: 2025, with € 75,588 profit.
A new publication or filing at SANIFORT PHARMA? We notify you, reason included.
Follow SANIFORT PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind SANIFORT PHARMA are Karel Vandecasteele, Leo Derieuw and Johan Jacobs. The same people are also behind PE GROUP and ILJO CONSULT.
Directors
According to the 2025 annual accounts
since 2007
Leo Derieuw
Director
since 2009
since 2009
Establishments
Establishment units
Physical locations of this company
Interleuvenlaan 62
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 97 companies are registered at this address.
SCHUT BELGIë
€ 33,349 gross margin · 2025
QUATTRO CLASSICS
€ 12,672 gross margin · 2025
Business Brewery
€ 385,638 gross margin · 2025
There
€ 487,247 gross margin · 2025
SWILLEN - NEESEN
+92 more
Details
- Company number
- 0882.765.326
- VAT number
- BE 0882.765.326
- Registered office
- Interleuvenlaan 62, 3001 Leuven
- Names & denominations
- SANIFORT PHARMA · SP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 24 July 2006
- Peppol
- Active · Active since 29 Oct 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Groothandel in parfumerieën en cosmetica
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels